clinical trial

(redirected from Clinical trials)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to Clinical trials: Clinical research

clinical trial

[¦klin·i·kəl ′trīl]
(medicine)
A research study used to find better ways to treat individuals with a specific disease, patients are evaluated after being administered a new treatment or drug.
References in periodicals archive ?
The CROs functioned as independent entities, performing clinical trials for their pharma clients and vouching for the quality of the data submitted to regulatory agencies for marketing approval (and sometimes, rejection).
In these, and in all clinical trials, investigators must clearly inform everyone who asks to participate about potential benefits and risks.
Top Countries Contributing to Clinical Trials in Asia-Pacific
Acurian's investigator database, which is the largest in the industry, includes professional credentials, clinical trial experience, location, performance metrics, disease specialties and patient demographics, in addition to numerous other data points.
Participation in clinical trials essentially requires three Ingredients: (1) physicians willing to refer patients to clinical trials: (2) patients willing to participate and accept the uncertainty of randomization: and (3) a mechanism to pay for the therapy.
Many payers might be more receptive to funding clinical trials if the diffusion of investigational therapies could be restricted until adequate outcomes data could be collected.
Neurotoxicity Syndromes Global Clinical Trials Review, Q1, 2011
The clinical trial process: technology in clinical trials
In addition to continuing its research on HIV treatment trials, the award provides funds for the Case Clinical Trials Unit to participate in the newly established Microbicides Trials Network.
GTx is conducting a separate pivotal Phase III clinical trial evaluating ACAPODENE 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN).
XenoPort's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the ability of the company to successfully conduct the clinical trials for XP13512 and XP19986; the uncertainty of the FDA approval process and other regulatory requirements; and the therapeutic and commercial value of the company's compounds.
Somaxon has previously reported the results of three Phase 3 clinical trials evaluating SILENOR[TM] for the treatment of insomnia.

Full browser ?